CT scans can show stomach cancer, and they are the primary imaging tool doctors use to evaluate suspected gastric tumors and determine how far the disease has spread. However, CT scans are significantly better at detecting advanced stomach cancer than catching it in its earliest stages. For early-stage tumors confined to the stomach lining, a CT scan picks up only about half of cases, making endoscopy the preferred method for initial diagnosis.
What a CT Scan Can Detect
When a radiologist reviews a CT scan for stomach cancer, they’re looking for several specific signs. The most common indicator is abnormal thickening of the stomach wall. A healthy stomach wall is thin and uniform, so any focal or diffuse thickening raises suspicion. In a pattern called linitis plastica, the entire stomach wall thickens symmetrically and loses its ability to stretch, a hallmark of an aggressive diffuse-type cancer.
Radiologists also look at how different layers of the stomach wall absorb contrast dye. A finding called the “malignant target sign” occurs when the inner lining lights up brightly while a deeper layer appears darker than normal. This layered pattern helps distinguish cancerous thickening from benign causes. These signs are most visible during specific phases of the scan, which is why the timing of contrast injection matters.
Accuracy by Cancer Stage
CT scans perform very differently depending on how advanced the cancer is. For tumors that have grown through the stomach wall into nearby organs (T4 stage), CT has 100% sensitivity, meaning it catches every case. For earlier tumors that haven’t penetrated as deeply (T1/T2), sensitivity drops to about 71%. The overall accuracy of tumor depth staging on CT ranges from about 78% to 85%, depending on the radiologist’s experience and whether findings are reviewed by consensus.
The weakest spot is the earliest stage. For T1 tumors, those still confined to the stomach’s inner layers, CT detects only about 52% of cases. Endoscopic ultrasound performs considerably better here, catching roughly 71% of T1 tumors. That gap is statistically significant and explains why endoscopy, not CT, is the go-to tool when doctors need to find or rule out early stomach cancer. CT and endoscopic ultrasound have nearly identical specificity for early tumors (around 94%), meaning both are equally good at correctly identifying a healthy stomach as cancer-free.
Checking for Cancer Spread
Where CT truly excels is in detecting whether stomach cancer has spread to other parts of the body. CT is considered the preoperative reference standard for finding distant metastases in gastric cancer patients, and it’s the imaging method recommended in European oncology guidelines for this purpose.
The numbers back this up. For detecting cancer spread to the peritoneum (the membrane lining the abdominal cavity, one of the most common places stomach cancer spreads), CT has about 90% sensitivity and 97% specificity. For liver metastases, sensitivity is around 80% with 99% specificity. Pelvic metastases are detected with 100% sensitivity and 99% specificity. For lymph node involvement near the stomach, CT reaches about 88% sensitivity, though specificity drops to around 60%, meaning it sometimes flags normal lymph nodes as suspicious.
The accuracy for overall metastasis staging (M staging) reaches 94% when images are reviewed carefully. This makes CT indispensable for treatment planning, because whether cancer has spread beyond the stomach fundamentally changes the options available.
How the Scan Is Performed
A standard abdominal CT won’t always give the clearest view of the stomach. For suspected gastric cancer, doctors often use a dedicated stomach protocol. You’ll typically drink water or an oral contrast agent before the scan to expand the stomach. This distension is critical because a collapsed, empty stomach can hide wall thickening and small masses. Studies show that using oral contrast produces significantly better clarity of the stomach lining and better expansion of the stomach compared to water alone.
An IV contrast dye is also injected during the scan, and images are captured at multiple time points as the dye moves through your bloodstream. Different phases of contrast absorption reveal different things: arterial-phase images highlight the blood-rich inner lining, while later venous-phase images show deeper layers and help evaluate lymph nodes and distant organs. The entire scan takes only a few minutes, though you may spend 30 to 60 minutes in the facility for preparation and the contrast to take effect.
When CT Is Used vs. Endoscopy
CT and endoscopy answer different questions. An upper endoscopy (where a flexible camera is passed down your throat) is the tool used to find the cancer in the first place. It lets doctors see the stomach lining directly, take tissue samples for biopsy, and confirm a diagnosis. No imaging scan replaces that direct visualization for initial detection.
CT enters the picture after a diagnosis is confirmed, or when doctors already suspect advanced disease. Its job is staging: determining how deep the tumor has grown, whether lymph nodes are involved, and whether cancer has reached the liver, peritoneum, or other organs. This information directly shapes whether surgery is an option, whether chemotherapy should come first, or whether the focus shifts to managing symptoms.
In some cases, both tools are used together. Endoscopic ultrasound provides the best detail about tumor depth in early stages, while CT provides the broadest view of the entire abdomen and chest for distant spread. Combining the two gives the most complete picture, with studies showing that the pairing offers both high sensitivity and improved specificity for early-stage assessment.
What CT Can Miss
CT has notable blind spots. Very small or flat tumors that don’t cause obvious wall thickening can go undetected, which is why nearly half of T1-stage cancers are missed. Peritoneal spread in the form of tiny, scattered deposits (peritoneal carcinomatosis) can also be difficult to see on CT, even though the overall detection rate for peritoneal metastases is high. When deposits are very small or blend with surrounding tissue, the scan may not flag them.
Stomach distension also matters more than most patients realize. If you don’t drink enough fluid before the scan, or if the stomach doesn’t expand adequately, masses near the stomach wall can be obscured. Tumors located close to or merging with loops of intestine can be hard to measure accurately. Poor distension has been linked to difficulties evaluating peritoneal deposits and accurately sizing tumors in studies comparing different preparation methods.
Lymph node evaluation presents another challenge. CT identifies suspicious lymph nodes primarily by their size, but cancerous nodes aren’t always enlarged, and enlarged nodes aren’t always cancerous. This explains the relatively low 60% specificity for lymph node staging, where the scan over-calls cancer in healthy nodes fairly often.